RESEARCH TRIANGLE PARK (RTP), North Carolina, USA and HEIDELBERG, Germany — TCG (Technology Commercialization Group, LLC), an international life sciences firm headquartered in the Research Triangle Park region of North Carolina with offices in Heidelberg, Germany, is pleased to announce that the firm saw excellent growth throughout 2015. The TCG executive team provides interim management and transaction advisory services (licensing, partnering, M&A) for medical device, pharmaceutical, and biotechnology companies. In 2015, we:

  • Completed eleven strategic transactions and financings;
  • Served ten companies in Interim Management roles as CEO or as senior Business Development Executives, including companies from Switzerland, Canada, the UK, Norway, Israel and the US;
  • Added a new TCG Partner, Mike Garrett who offers 20+ years of legal and business development experience in the UK, France, Germany and the US;
  • Enhanced our financing advisory activity through our affiliation with Daybreak Capital Partners, a New York-based investment banking firm.

We are beginning 2016 with eight interim management roles and with thirteen transactions and financing projects currently in progress. As financing and the numbers of transactions continue to grow in the life sciences sector, TCG is expecting significant activity throughout 2016. Contact us to learn how we can help you grow your business.

To learn more about our team of executives, white papers and case studies, please see our website www.tcgmedtech.com. Meet us at an upcoming meetings, or contact us directly at our US or European offices:  USA: (919) 941-0700  Europe: +49-6221-27262

About TCG: Founded in 1998, TCG serves life science companies, including medical device, pharmaceutical, and biotechnology companies from its headquarters in the Research Triangle Park region of North Carolina, USA and offices in Heidelberg, Germany. TCG leads and advises transactions, including licensing, strategic partnerships, distribution agreements, asset sales, financings, and acquisitions. TCG also provides interim management, when an experienced executive is needed for a critical project, to enter a new market, to develop a new strategy, or to refocus a company. TCG’s approach is different from other firms in that only senior TCG partners, with over 25 years of life science industry experience, lead assignments.  A global network of industry contacts helps TCG achieve their clients’ objectives rapidly. TCG has successfully completed hundreds of life science projects and assignments.